SE454744B - Forfarande for framstellning av ett laxativ pa basis av plantagofron och sennafrukter samt det hervid framstellda laxativet - Google Patents
Forfarande for framstellning av ett laxativ pa basis av plantagofron och sennafrukter samt det hervid framstellda laxativetInfo
- Publication number
- SE454744B SE454744B SE8100207A SE8100207A SE454744B SE 454744 B SE454744 B SE 454744B SE 8100207 A SE8100207 A SE 8100207A SE 8100207 A SE8100207 A SE 8100207A SE 454744 B SE454744 B SE 454744B
- Authority
- SE
- Sweden
- Prior art keywords
- laxative
- plantago
- weight
- fruits
- seeds
- Prior art date
Links
- 230000002475 laxative effect Effects 0.000 title claims description 45
- 239000008141 laxative Substances 0.000 title claims description 43
- 238000000034 method Methods 0.000 title claims description 13
- 238000002360 preparation method Methods 0.000 title claims description 5
- 101100020619 Arabidopsis thaliana LATE gene Proteins 0.000 title 1
- 229940124513 senna glycoside Drugs 0.000 claims description 24
- 241001127637 Plantago Species 0.000 claims description 22
- 235000006693 Cassia laevigata Nutrition 0.000 claims description 19
- 241000522641 Senna Species 0.000 claims description 19
- 235000013399 edible fruits Nutrition 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000000227 grinding Methods 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 11
- 229940018492 plantago seed Drugs 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 9
- 239000010903 husk Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 241000209051 Saccharum Species 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 3
- 229920000084 Gum arabic Polymers 0.000 claims description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 3
- 239000007931 coated granule Substances 0.000 claims description 3
- 239000004407 iron oxides and hydroxides Substances 0.000 claims description 3
- 239000000454 talc Substances 0.000 claims description 3
- 229910052623 talc Inorganic materials 0.000 claims description 3
- 235000012222 talc Nutrition 0.000 claims description 3
- 238000009826 distribution Methods 0.000 claims description 2
- 235000012054 meals Nutrition 0.000 claims description 2
- 210000003097 mucus Anatomy 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims 2
- 244000056139 Brassica cretica Species 0.000 claims 1
- 235000003351 Brassica cretica Nutrition 0.000 claims 1
- 235000003343 Brassica rupestris Nutrition 0.000 claims 1
- 244000300264 Spinacia oleracea Species 0.000 claims 1
- 235000009337 Spinacia oleracea Nutrition 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims 1
- 238000001125 extrusion Methods 0.000 claims 1
- 238000005469 granulation Methods 0.000 claims 1
- 230000003179 granulation Effects 0.000 claims 1
- 238000003801 milling Methods 0.000 claims 1
- 235000010460 mustard Nutrition 0.000 claims 1
- 239000002002 slurry Substances 0.000 claims 1
- 241001465754 Metazoa Species 0.000 description 25
- 241000700159 Rattus Species 0.000 description 17
- 230000000694 effects Effects 0.000 description 11
- 229930186851 sennoside Natural products 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 8
- 210000003608 fece Anatomy 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- IPQVTOJGNYVQEO-UHFFFAOYSA-N 9-[2-carboxy-4-hydroxy-10-oxo-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9h-anthracen-9-yl]-4-hydroxy-10-oxo-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9h-anthracene-2-carboxylic acid Chemical class OC1C(O)C(O)C(CO)OC1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1C2C1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(OC3C(C(O)C(O)C(CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-UHFFFAOYSA-N 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 230000008595 infiltration Effects 0.000 description 5
- 238000001764 infiltration Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- IPQVTOJGNYVQEO-KGFNBKMBSA-N sennoside A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-KGFNBKMBSA-N 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 244000134552 Plantago ovata Species 0.000 description 4
- 235000003421 Plantago ovata Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000002550 fecal effect Effects 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 229940125722 laxative agent Drugs 0.000 description 4
- 238000012453 sprague-dawley rat model Methods 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 230000001989 choleretic effect Effects 0.000 description 2
- 230000007665 chronic toxicity Effects 0.000 description 2
- 231100000160 chronic toxicity Toxicity 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000003736 gastrointestinal content Anatomy 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000021231 nutrient uptake Nutrition 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000005029 sieve analysis Methods 0.000 description 2
- 231100000456 subacute toxicity Toxicity 0.000 description 2
- 230000003390 teratogenic effect Effects 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 241000612182 Rexea solandri Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000007580 dry-mixing Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000012623 in vivo measurement Methods 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 230000036325 urinary excretion Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3001357A DE3001357C2 (de) | 1980-01-16 | 1980-01-16 | Granuliertes Abführmittel auf der Basis von Plantagosamen und Sennesfrüchten und Verfahren zur Herstellung desselben |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8100207L SE8100207L (sv) | 1981-07-17 |
| SE454744B true SE454744B (sv) | 1988-05-30 |
Family
ID=6092153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8100207A SE454744B (sv) | 1980-01-16 | 1981-01-15 | Forfarande for framstellning av ett laxativ pa basis av plantagofron och sennafrukter samt det hervid framstellda laxativet |
Country Status (26)
| Country | Link |
|---|---|
| AR (1) | AR222269A1 (is") |
| AT (1) | AT372280B (is") |
| AU (1) | AU547152B2 (is") |
| BE (1) | BE887111A (is") |
| CA (1) | CA1167769A (is") |
| CH (1) | CH650403A5 (is") |
| CS (1) | CS227324B2 (is") |
| DE (1) | DE3001357C2 (is") |
| DK (1) | DK153774C (is") |
| FI (1) | FI75095C (is") |
| FR (1) | FR2473311A1 (is") |
| GB (1) | GB2067402B (is") |
| GR (1) | GR73649B (is") |
| HK (1) | HK75984A (is") |
| IE (1) | IE50621B1 (is") |
| IT (1) | IT1135052B (is") |
| LU (1) | LU83058A1 (is") |
| MX (1) | MX7112E (is") |
| NL (1) | NL188452C (is") |
| NO (1) | NO153594C (is") |
| NZ (1) | NZ196034A (is") |
| PT (1) | PT72358B (is") |
| SE (1) | SE454744B (is") |
| SU (1) | SU1145911A3 (is") |
| YU (1) | YU42551B (is") |
| ZA (1) | ZA81254B (is") |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4321263A (en) * | 1980-09-30 | 1982-03-23 | Rowell Laboratories, Inc. | Psyllium compositions |
| US5009916A (en) * | 1983-12-12 | 1991-04-23 | The Procter & Gamble Company | Psyllium mucilloid fiber food products |
| EP0144644B1 (en) * | 1983-12-12 | 1989-09-06 | THE PROCTER & GAMBLE COMPANY | Psyllium mucilloid products |
| US4950689A (en) * | 1987-03-31 | 1990-08-21 | Yang Robert K | Pectin delivery system |
| ATE92328T1 (de) * | 1989-08-10 | 1993-08-15 | Procter & Gamble | Essbare saeure enthaltende agglomerierte psyllium- spelze. |
| US5219570A (en) * | 1989-08-10 | 1993-06-15 | The Procter & Gamble Company | Agglomerated psyllium husk containing edible acid |
| US5126150A (en) * | 1990-10-01 | 1992-06-30 | The Procter & Gamble Company | Compositions containing psyllium |
| GB2272374B (en) * | 1992-11-13 | 1996-07-03 | Asta Medica Ag | Stable senna extract formulations |
| FR2723318B1 (fr) * | 1994-08-04 | 1999-09-03 | Chicouri Marcel | Nouvelles compositions laxatives et leur procede de preparation |
| US20050053676A1 (en) * | 2003-09-05 | 2005-03-10 | Madaus Ag | Powdered composition for use as laxative |
| ES2320827B1 (es) * | 2006-12-29 | 2010-03-03 | Madaus, S.A. | "composicion farmaceutica que contiene psyllium y senna". |
| DE102007023397B4 (de) | 2007-05-02 | 2015-03-26 | Madaus Gmbh | Neue pharmazeutische Zusammensetzung zur Verwendung als Laxativum |
| DE202007007143U1 (de) | 2007-05-02 | 2008-06-12 | Madaus Gmbh | Neue pharmazeutische Zusammensetzung zur Verwendung als Laxativum |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1847247A (en) * | 1931-02-14 | 1932-03-01 | Jones William Thomas | Mechanical laxative |
| DE1003916B (de) * | 1954-05-12 | 1957-03-07 | Westminster Lab Ltd | Verfahren zur Herstellung von Sennespraeparaten |
| GB829068A (en) * | 1958-04-09 | 1960-02-24 | Mundipharma Ag | Improvements in novel laxative agents |
| DE1103520B (de) * | 1959-08-12 | 1961-03-30 | Madaus & Co Dr | Verfahren zur Herstellung eines Abfuehrmittels |
| DE2629773C2 (de) * | 1976-07-02 | 1985-06-27 | Thiele, Henry, Dipl.-Ing. Dr., 7534 Birkenfeld | Produkt aus Kleie und Pektin |
-
1980
- 1980-01-16 DE DE3001357A patent/DE3001357C2/de not_active Expired
-
1981
- 1981-01-13 CA CA000368439A patent/CA1167769A/en not_active Expired
- 1981-01-14 FI FI810095A patent/FI75095C/fi not_active IP Right Cessation
- 1981-01-14 GB GB8101047A patent/GB2067402B/en not_active Expired
- 1981-01-14 DK DK015181A patent/DK153774C/da not_active IP Right Cessation
- 1981-01-14 LU LU83058A patent/LU83058A1/de unknown
- 1981-01-15 SE SE8100207A patent/SE454744B/sv not_active IP Right Cessation
- 1981-01-15 NO NO810133A patent/NO153594C/no unknown
- 1981-01-15 ZA ZA00810254A patent/ZA81254B/xx unknown
- 1981-01-15 CS CS81297A patent/CS227324B2/cs unknown
- 1981-01-15 IE IE74/81A patent/IE50621B1/en not_active IP Right Cessation
- 1981-01-15 PT PT72358A patent/PT72358B/pt not_active IP Right Cessation
- 1981-01-15 CH CH247/81A patent/CH650403A5/de not_active IP Right Cessation
- 1981-01-15 GR GR63874A patent/GR73649B/el unknown
- 1981-01-15 AU AU66241/81A patent/AU547152B2/en not_active Ceased
- 1981-01-15 AT AT0014681A patent/AT372280B/de not_active IP Right Cessation
- 1981-01-15 IT IT19154/81A patent/IT1135052B/it active
- 1981-01-15 NL NLAANVRAGE8100167,A patent/NL188452C/xx not_active IP Right Cessation
- 1981-01-16 AR AR283983A patent/AR222269A1/es active
- 1981-01-16 YU YU95/81A patent/YU42551B/xx unknown
- 1981-01-16 MX MX819267U patent/MX7112E/es unknown
- 1981-01-16 SU SU813238931A patent/SU1145911A3/ru active
- 1981-01-16 FR FR8100819A patent/FR2473311A1/fr active Granted
- 1981-01-16 NZ NZ196034A patent/NZ196034A/en unknown
- 1981-01-16 BE BE0/203510A patent/BE887111A/fr not_active IP Right Cessation
-
1984
- 1984-10-04 HK HK759/84A patent/HK75984A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4511561A (en) | Laxative composition comprising psyllium seeds and senna fruits | |
| SE454744B (sv) | Forfarande for framstellning av ett laxativ pa basis av plantagofron och sennafrukter samt det hervid framstellda laxativet | |
| CN110269915B (zh) | 一种减肥降脂组合物及其制备方法 | |
| KR101149431B1 (ko) | 완하제로 사용하기 위한 신규약제 조성물 | |
| CN114727961A (zh) | 包含天然产物提取物的具有改善的稳定性的药物组合物 | |
| CN115316667A (zh) | 一种有助于润肠通便的保健食品组合物及其制备方法 | |
| CN109419847A (zh) | 一种鲜益母草三七中药组合物及其制备方法 | |
| CN109481515B (zh) | 一种促消化功能的固体分散体泡腾片 | |
| WO2014134833A1 (zh) | 可食用组合物及其制备方法和包含该组合物的食品 | |
| CN116138454B (zh) | 一种具有缓解便秘作用的枸杞子药食两用组合物及其制备方法与应用 | |
| RU2207143C1 (ru) | Биологически активная добавка "бронхоастмин" для профилактики и поддерживающей терапии бронхиальной астмы и воспалительных заболеваний органов дыхания | |
| CN116077609B (zh) | 治疗ibd、ibs的黄厚止泻速释微丸及其制备方法 | |
| JPS6026375B2 (ja) | プシリウム子及びセンナ実よりなる緩下剤 | |
| RU2189830C1 (ru) | Биологически активная добавка "лактогон" | |
| CN115252710B (zh) | 一种用于治疗便秘的药物的制备方法、所制药物及其应用 | |
| DD157666A1 (de) | Verfahren zur herstellung eines abfuehrmittels | |
| CN101317953A (zh) | 一种滋液熄风滋养阴液胶囊的制作方法 | |
| RU2185845C2 (ru) | Биологически активная пищевая добавка "почечные" | |
| RU2233667C1 (ru) | Препарат "фитохолециститные" для профилактики и вспомогательной терапии при лечении заболеваний печени и желчевыводящих путей | |
| RU2214266C1 (ru) | Биологически активная добавка "слабительные травы" | |
| DE10346083A1 (de) | Pulverförmige Zusammensetzung zur Verwendung als Laxativum | |
| CN119770580A (zh) | 一种降低血清尿酸水平的组合物、保健食品或药物 | |
| CN113181277A (zh) | 一种治疗便秘的中药组合物及其应用 | |
| RU2246960C2 (ru) | Препарат "поджелудочные травы" для профилактики и поддерживающей терапии при лечении заболеваний поджелудочной железы | |
| CN112316125A (zh) | 一种基于水蛭素的中药组合物及其微丸的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8100207-3 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8100207-3 Format of ref document f/p: F |